Agilon Health (NYSE:AGL) Trading Up 5.4% - Here's Why

Key Points

• Agilon Health shares rose 5.4% to about $98.68, although trading volume was roughly 90% below the average session volume.
• The company beat quarterly expectations, reporting $1.04 in EPS versus the $0.14 consensus and revenue of $1.49 billion versus estimates of $1.45 billion. Analysts nevertheless expect a full-year loss of $2.95 per share.
• Analyst sentiment remains mixed: five analysts rate the stock Buy, seven Hold and two Sell, producing a consensus Hold rating and an average price target of $91.30.

Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) traded up 5.4% on Thursday . The stock traded as high as $100.00 and last traded at $98.6820. Approximately 33,811 shares changed hands during trading, a decline of 90% from the average session volume of 354,760 shares. The stock had previously closed at $93.64.

Wall Street Analyst Weigh In

Several equities research analysts have commented on AGL shares. Weiss Ratings lowered Agilon Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, May 27th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Robert W. Baird set a $116.00 target price on shares of Agilon Health in a research note on Thursday, August 6th. Wall Street Zen raised shares of Agilon Health from a "sell" rating to a "hold" rating in a report on Saturday, May 9th. Finally, Jefferies Financial Group upgraded shares of Agilon Health from a "hold" rating to a "buy" rating and raised their price target for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $91.30.

Agilon Health Stock Up 4.2%

The company has a market cap of $1.64 billion, a price-to-earnings ratio of -6.84 and a beta of 3.01. The business has a fifty day moving average of $106.62 and a two-hundred day moving average of $60.12. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. As a group, equities analysts anticipate that Agilon Health, Inc. will post -2.95 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Alpine Global Management LLC purchased a new position in Agilon Health during the fourth quarter valued at $84,000. Invesco Ltd. increased its stake in shares of Agilon Health by 30.7% during the fourth quarter. Invesco Ltd. now owns 1,004,266 shares of the company's stock worth $692,000 after purchasing an additional 235,951 shares in the last quarter. Sei Investments Co. raised its position in shares of Agilon Health by 1,612.7% during the 2nd quarter. Sei Investments Co. now owns 216,617 shares of the company's stock worth $498,000 after purchasing an additional 203,969 shares during the last quarter. Creative Planning raised its position in shares of Agilon Health by 17.6% during the 2nd quarter. Creative Planning now owns 170,969 shares of the company's stock worth $393,000 after purchasing an additional 25,548 shares during the last quarter. Finally, State of Wyoming lifted its stake in Agilon Health by 31.1% in the 2nd quarter. State of Wyoming now owns 168,461 shares of the company's stock valued at $387,000 after buying an additional 39,952 shares in the last quarter.

About Agilon Health

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source